| J9298 | Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg | 6,410 | $140 | $891.1K |
| J9271 | Injection, pembrolizumab, 1 mg | 19,010 | $40 | $817.2K |
| J9299 | Injection, nivolumab, 1 mg | 27,260 | $20 | $654.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 500 | $150 | $72.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 470 | $100 | $49K |
| J0897 | Injection, denosumab, 1 mg | 2,700 | $20 | $48.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 320 | $120 | $37.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 260 | $70 | $18.3K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 160 | $100 | $16.1K |
| 99443 | N/A | 70 | $110 | $7.4K |